MedTrace Logo

Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated Patients Using the AnapnoGuard System

NCT01126320 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 161

Last updated 2016-02-19

No results posted yet for this study

Summary

Ventilator Associated Pneumonia (VAP) is a common complication experienced by mechanically ventilated patients and within the framework of Respiratory Intensive Care Units. The AnapnoGuard system, developed by Hospitech Respiration Ltd. is a ventilation guard system that includes a number of unique characteristics. This study was designed to test the frequency VAP in mechanically ventilated ICU patients using the AnapnoGuard System.

Conditions

  • Ventilator Associated Pneumonia

Interventions

DEVICE

AnapnoGuard 100,

Respiratory guard system during mechanical ventilation with routine mechanical ventilator

DEVICE

routine mechanical ventilator

routine mechanical ventilation

Sponsors & Collaborators

  • Hospitech Respiration

    lead INDUSTRY

Principal Investigators

  • Yaron Bar Lavi, Dr. · RAMBAM Medical Center, Haifa Israel

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2015-07-31
Completion
2015-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01126320 on ClinicalTrials.gov